- Asked by: Tim Eagle, MSP for Highlands and Islands, Scottish Conservative and Unionist Party
-
Date lodged: Monday, 27 July 2026
-
Current Status:
Answered by Angela Constance on 13 August 2026
To ask the Scottish Government what further support it can provide to NHS Highland to ensure its oncology department can meet local demand.
Answer
The Scottish Government convened a meeting on 24 July with Board Chief Executives and Medical Directors to discuss the current situation in NHS Highland to ensure the risks are being mitigated and the system is working collaboratively to do this.
Whilst this is an operational issue for NHS Highland the Scottish Government remains in close contact with the Health Board at this time.
- Asked by: Tim Eagle, MSP for Highlands and Islands, Scottish Conservative and Unionist Party
-
Date lodged: Monday, 27 July 2026
-
Current Status:
Answered by Angela Constance on 13 August 2026
To ask the Scottish Government what its response is to reports that NHS Highland has not confirmed whether cancer patients who are required to travel to another NHS board to receive treatment will be able to claim back the cost of (a) travel and (b) accommodation.
Answer
I refer the member to the answer to question S7W-02052 on13 August 2026.
The Scottish Government provides the overall guidance to NHS Boards for patient travel expenses reimbursement - individual Boards are responsible for developing and applying their own policies, including reimbursement rates, ensuring patient care and safety.
The Patient Travel Expenses Scheme (PTES) is Scotland-wide and provides support to those in receipt of certain benefits. Financial support for travel is available for patients and authorised escorts, according to eligibility criteria and medical requirements.
All Boards are expected to support patients and their families in identifying and accessing available support and Board patient travel contacts can provide advice on eligibility and assistance available with bookings and advance payments, where necessary. The costs of the reimbursement schemes are met from Boards’ budgets.
All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers.
- Asked by: Martyn Day, MSP for Falkirk East and Linlithgow, Scottish National Party
-
Date lodged: Tuesday, 21 July 2026
-
Current Status:
Answered by Maree Todd on 13 August 2026
To ask the Scottish Government what the timetable is for the delivery of equitable 24/7 national access to thrombectomy services.
Answer
Public Services Delivery Scotland are obtaining the requisite clinical, planning, financial and staffing information from NHS Boards to understand what would be required to make 24/7 thrombectomy available across Scotland.
We expect this financial case for expansion to be produced by the end of October. We will then work at pace to produce a delivery plan with timescales for service expansion.
- Asked by: Adam Harley, MSP for Strathkelvin and Bearsden, Scottish Liberal Democrats
-
Date lodged: Monday, 03 August 2026
-
Current Status:
Answered by Alison Thewliss on 13 August 2026
To ask the Scottish Government what the final amount spent on the proposed National Care Service is, broken down by category of expenditure.
Answer
The budgets including NCS costs covering the period 2021-2026 are available on the Scottish Government’s website.
Within the budget for year 2026-27 £50,000 is provisioned for the spend on the on-going running of the National Care Service Advisory Board. This includes the costs of supporting the Advisory Board Who continue to play an active role in shaping the Scottish Government’s delivery of the Care Reform (Scotland) Act 2025.
- Asked by: Tim Eagle, MSP for Highlands and Islands, Scottish Conservative and Unionist Party
-
Date lodged: Monday, 27 July 2026
-
Current Status:
Answered by Angela Constance on 13 August 2026
To ask the Scottish Government what its response is to reports that, as a result of a loss of oncology consultant capacity, cancer patients in NHS Highland’s catchment area will experience delays to treatment or be required to travel to another NHS board for treatment.
Answer
This is an operational decision for NHS Highland.
The Scottish Government wants people diagnosed with cancer to be treated as close to home as clinically possible. We recognise that NHS Scotland’s oncology capacity has been increasingly tested and continue to work with NHS Boards to limit the need for travel where possible and clinically appropriate.
- Asked by: Miles Briggs, MSP for Edinburgh and Lothians East, Scottish Conservative and Unionist Party
-
Date lodged: Wednesday, 22 July 2026
-
Current Status:
Answered by Maree Todd on 13 August 2026
To ask the Scottish Government what progress has been made in implementing the Scottish Health Technologies Group's recommendation of February 2026 that lidocaine infusions, lidocaine injections and radiofrequency treatment should be available for suitable patients with chronic pain.
Answer
NHS Scotland is required to consider the Scottish Health Technologies Group's(SHTG) recommendations. Discussions are underway to understand how those recommendations can inform sustainable, consistent and effective service delivery across Scotland.
We are working with NHSScotland partners to ensure appropriate representation from both NHS services and people living with chronic pain.
- Asked by: Jackie Baillie, MSP for Dumbarton, Scottish Labour
-
Date lodged: Monday, 20 July 2026
-
Current Status:
Answered by Maree Todd on 13 August 2026
To ask the Scottish Government what assessment it has made of the extent to which increased access to mechanical thrombectomy could reduce demand for inpatient stroke rehabilitation services in NHS Greater Glasgow and Clyde.
Answer
The Scottish Government has not conducted a specific analysis of the impact of thrombectomy access on inpatient stroke rehabilitation services in NHS Greater Glasgow and Clyde.
We would expect Public Services Delivery Scotland (PSDS)to consider all aspects of service impact, including the impact on demand for rehabilitation services, when considering the resource requirements to make 24/7 thrombectomy available across Scotland.
- Asked by: Miles Briggs, MSP for Edinburgh and Lothians East, Scottish Conservative and Unionist Party
-
Date lodged: Wednesday, 22 July 2026
-
Current Status:
Answered by Maree Todd on 13 August 2026
To ask the Scottish Government for what reason the first meeting of the group established to consider the Scottish Health Technologies Group's recommendation that lidocaine infusions, lidocaine injections and radiofrequency treatment should continue for suitable chronic pain patients, scheduled for 29 April 2026, was cancelled, and whether it will publish details of the group's leadership, membership and remit.
Answer
The meeting planned to take place on the 29 April 2026, to discuss the formation of a short life working group to look at interventions for chronic pain, was cancelled to allow full consideration of the group’s remit, methodology, and membership.
As this group has not been established, no information is available for publication concerning its leadership, membership, or remit.
- Asked by: Martyn Day, MSP for Falkirk East and Linlithgow, Scottish National Party
-
Date lodged: Tuesday, 21 July 2026
-
Current Status:
Answered by Maree Todd on 13 August 2026
To ask the Scottish Government how it will use the findings from the forthcoming Scottish Stroke Improvement Programme audit to support the delivery of equitable national 24/7 access to thrombectomy services.
Answer
The Scottish Stroke Care Audit provides invaluable information that helps drive improvements in the delivery of stroke care, including hyperacute treatment such as thrombectomy.
In particular, the measurement of thrombolysis door-to-needle times allows the Scottish Stroke Improvement Programme to work with NHS Boards to improve hyperacute stroke care pathways.
We expect NHS Boards to identify aspects of their stroke services which do not meet the Scottish Stroke Care Standards and to work to improve their standards of care locally.
- Asked by: Martyn Day, MSP for Falkirk East and Linlithgow, Scottish National Party
-
Date lodged: Monday, 20 July 2026
-
Current Status:
Answered by Maree Todd on 13 August 2026
To ask the Scottish Government how it is working with the UK Government and National Institute for Health and Care Research (NIHR) to ensure that patients and researchers in Scotland can benefit from the NIHR Brain Tumour Research Consortium, and what role Scotland will play in the programme.
Answer
The Scottish Government works closely with the National Institute for Health & Care (NIHR) including buying into the majority of their research funding programmes to allow access for researchers based in Scotland NIHR Programmes – Chief Scientist Office
The Scottish Government will reach out to the relevant team within NIHR to discuss how the NIHR Brain Tumour Research Consortium will be fully implemented here for the benefit of both patients and researchers.